LOS ANGELES, December 13, 2023 – Clubhouse Media Group, Inc. (OTC: CMGR) (“Clubhouse Media Group”), a social media firm and digital agency, today announced that
NEW YORK, NY, December 13, 2023 – Quoin Pharmaceuticals (Nasdaq: QNRX) has received U.S. Food and Drug Administration (FDA) clearance to implement several protocol amendments to its
NEW YORK, NY, December 13, 2023 – ReShape Lifesciences (Nasdaq: RSLS) has been granted FDA approval of a PMA supplement for the company’s next generation, enhanced Lap-Band® 2.0 FLEX.
NEW YORK, NY, December 13, 2023 – US equities closed mostly higher on Tuesday as the S&P set a fresh year-to-date high, finishing the day
Leading global companies work to strike balance between digital and traditional advertising Industry experts point to 2H 2024 for AdTech and Media IPO market to
Naples, FL, December 12, 2023 – Industrial Nanotech Inc. (OTC: INTK) today announced that Stuart Burchill, the group’s founding Chairman and Chief Executive Officer has
NEW YORK, NY, December 12, 2023 – An immersive technology platform company, Glimpse recently announced its plans for a strategic shift from current immersive technologies that include
Dover, DE, December 12, 2023 – Metatron Apps Inc. (OTC: MRNJ), a prominent figure in the digital technology sector with a portfolio boasting over 1000
West Palm Beach, FL., December 12, 2023 -OpenLocker Holdings Inc., (“OpenLocker” or the “Company”) (OTCQB: OLKR) is pleased to announce the release of the following
NEW YORK, NY, December 11, 2023 – The FDA has cleared an Investigational New Drug Application (IND) for MyMD Pharmaceuticals (Nasdaq: MYMD) to initiate a Phase 2 clinical trial
PRISM MediaWire
info@prismmediawire.com
Phone: 646-780-8850
